KC
RYZB

Kellner Capital’s RayzeBio, Inc. Common Stock RYZB Stock Holding History

Kellner Capital’s Portfolio RYZB Stock Details RYZB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		$758K Buy
+12,200
New +$303K 1.37% 17

Other funds holding RYZB

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Kellner Capital's RYZB Position: Q4 2023 in Review

Kellner Capital opened a new position in RayzeBio, Inc. Common Stock (RYZB) in Q4 2023: 12,200 shares worth $758K. The stake represents 1.37% of the portfolio and ranks #17 among its holdings.

107 funds tracked by Wall St. Rank hold RYZB as of Q4 2023.

  • Kellner Capital held 12,200 shares of RayzeBio, Inc. Common Stock worth $758K as of Q4 2023.
  • RayzeBio, Inc. Common Stock was a new Kellner Capital position in Q4 2023.
  • RayzeBio, Inc. Common Stock made up 1.37% of Kellner Capital's portfolio in Q4 2023, its #17 holding.
  • 107 funds tracked by Wall St. Rank held RayzeBio, Inc. Common Stock as of Q4 2023.

Based on Kellner Capital's 13F filing for Q4 2023, filed 7 Feb 2024.